Skip to content
Sign in

AEMD · NASDAQ

Aethlon Medical (AEMD) Stock Price & Fundamentals

$462.48−0.50%−$2.33End-of-day price as of Oct 9, 2026

Aethlon Medical (AEMD) closed at $462.48 on Oct 9, 2026, down 0.50% from the previous close of $464.81.

Share price, past year

1Y +16.00%

52-week range $355.84 – $466.76. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$462.48
Sep 30, 2026$459.46
Aug 31, 2026$442.01
Jul 31, 2026$437.16
Jun 30, 2026$423.32
May 29, 2026$399.96
Apr 30, 2026$374.43
Mar 31, 2026$369.44
Feb 27, 2026$365.09
Jan 30, 2026$364.01
Dec 31, 2025$377.37
Nov 28, 2025$383.52
Oct 31, 2025$392.86

Key statistics

Market cap
$220.79M
P/E (TTM)
16.6
EPS (TTM)
$27.79
Revenue (TTM)
—
Net income (TTM)
−$6.94M
Shares outstanding
477.4K
Dividend yield
—
52-week range
$355.84 – $466.76

Aethlon Medical's market cap is $220.79M, based on a share price of $462.48 and 477.4K shares outstanding as of Jun 30, 2026.

Financials

Aethlon Medical reported revenue of $0.00 for fiscal 2024, down 100.00% from fiscal 2023.

Aethlon Medical reported a net loss of $7.15M in fiscal 2026.

Annual revenue

FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24
Annual revenue by fiscal year; the table below lists the values.
Aethlon Medical annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2024ended Mar 31, 2024$0.00−100.0%−$12.21M—−$38.87−$10.38M
FY2023ended Mar 31, 2023$574.25K+95.2%−$12.03M−2,094.9%−$5.86−$11.45M
FY2022ended Mar 31, 2022$294.17K−55.4%−$10.42M−3,540.9%−$0.71−$10.12M
FY2021ended Mar 31, 2021$659.10K+1.4%−$7.89M−1,196.6%−$0.65−$6.82M
FY2020ended Mar 31, 2020$650.19K+183.2%−$6.37M−980.3%−$1.87−$5.35M
FY2019ended Mar 31, 2019$229.63K+53.5%−$6.19M−2,697.8%−$5.13−$4.29M
FY2018ended Mar 31, 2018$149.63K−61.8%−$5.68M−3,795.9%−$0.10−$3.94M
FY2017ended Mar 31, 2017$392.07K−55.8%−$7.28M−1,855.8%−$0.94−$3.52M
FY2016ended Mar 31, 2016$886.57K+16.3%————
FY2015ended Mar 31, 2015$762.42K—————
Aethlon Medical quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q4 FY2023ended Mar 31, 2023$574.25K——
Q3 FY2023ended Dec 31, 2022$0.00——
Q2 FY2023ended Sep 30, 2022$0.00——
Q1 FY2023ended Jun 30, 2022$0.00——
Q4 FY2022ended Mar 31, 2022$13.12K——
Q3 FY2022ended Dec 31, 2021$17.12K——
Q2 FY2022ended Sep 30, 2021$131.97K——
Q1 FY2022ended Jun 30, 2021$131.97K——

Company profile

Name
Aethlon Medical, Inc.
Ticker
AEMD
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
11555 Sorrento Valley Road, Suite 203, San Diego, CA 92121
Incorporated in
NV
Fiscal year ends
March
SEC CIK
0000882291

Recent SEC filings

Frequently asked questions

What is Aethlon Medical's stock price?

Aethlon Medical (AEMD) closed at $462.48 on Oct 9, 2026, down 0.50% from the previous close of $464.81.

What is Aethlon Medical's market cap?

Aethlon Medical's market cap is $220.79M, based on a share price of $462.48 and 477.4K shares outstanding as of Jun 30, 2026.

How much revenue does Aethlon Medical make?

Aethlon Medical reported revenue of $0.00 for fiscal 2024, down 100.00% from fiscal 2023.

What is AEMD's P/E ratio?

Aethlon Medical's price-to-earnings ratio is 16.6, based on trailing twelve-month diluted EPS of $27.79.

Does Aethlon Medical pay a dividend?

Aethlon Medical's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Aethlon Medical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures